Science Explorer Back to mapMap
Discussion
Company · Salt Lake City · United States

Q Therapeutics (United States)

qthera.comROR OpenAlex
Research works
116
▲ 136% vs 2018-21
Citations
1.5k
13.2 per fractional work
Top-10% rate
11.2%
all institutions 10.0%
Open access
50%
world 40%
International
20%
world 18%
Q Therapeutics (United States)

Not ranked overall: Q Therapeutics (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Q Therapeutics (United States) work in?

In 2022-now, 47% of research at Q Therapeutics (United States) is in Life Sciences, 33% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (35%), Medicine (33%), Arts and Humanities (13%). It does 2.9× the world's share of Life Sciences.

Life Sciences: 29 fractional works · 46.6% of its workBiochemistry, Genetics and Molecular Biology: 22 fractional works · 35.2% of its workMolecular Biology: 15 fractional works · 24.5% of its workGenetics: 3 fractional works · 5.3% of its workCancer Research: 2 fractional works · 2.7% of its workBiotechnology: 1 fractional works · 1.6% of its workBiochemistry: 0 fractional works · 0.5% of its workCell Biology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workImmunology and Microbiology: 5 fractional works · 7.8% of its workImmunology: 5 fractional works · 7.8% of its workNeuroscience: 1 fractional works · 1.5% of its workNeurology: 0 fractional works · 0.8% of its workBiological Psychiatry: 0 fractional works · 0.4% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.3% of its workAgricultural and Biological Sciences: 1 fractional works · 1.4% of its workAquatic Science: 0 fractional works · 0.5% of its workFood Science: 0 fractional works · 0.4% of its workPlant Science: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.7% of its workPharmacology: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.2% of its workHealth Sciences: 21 fractional works · 33.3% of its workMedicine: 21 fractional works · 33.3% of its workOncology: 11 fractional works · 17.2% of its workRadiology, Nuclear Medicine and Imaging: 4 fractional works · 5.7% of its workPulmonary and Respiratory Medicine: 2 fractional works · 2.7% of its workPhysiology: 1 fractional works · 1.2% of its workPharmacology: 0 fractional works · 0.8% of its workSurgery: 0 fractional works · 0.7% of its workRheumatology: 0 fractional works · 0.6% of its workEpidemiology: 0 fractional works · 0.5% of its workHepatology: 0 fractional works · 0.5% of its workImmunology and Allergy: 0 fractional works · 0.4% of its workInfectious Diseases: 0 fractional works · 0.3% of its workOphthalmology: 0 fractional works · 0.3% of its workGenetics: 0 fractional works · 0.3% of its workHematology: 0 fractional works · 0.3% of its workNephrology: 0 fractional works · 0.3% of its workNeurology: 0 fractional works · 0.2% of its workDermatology: 0 fractional works · 0.2% of its workRehabilitation: 0 fractional works · 0.2% of its workSmaller subfields together: 1 fractional works · 0.9% of its workSocial Sciences: 11 fractional works · 17.5% of its workArts and Humanities: 8 fractional works · 13.4% of its workMuseology: 3 fractional works · 4.3% of its workLanguage and Linguistics: 2 fractional works · 3.7% of its workLiterature and Literary Theory: 2 fractional works · 3.2% of its workHistory: 1 fractional works · 1.1% of its workReligious studies: 1 fractional works · 1.1% of its workSocial Sciences: 1 fractional works · 2.3% of its workSociology and Political Science: 1 fractional works · 1.2% of its workEducation: 1 fractional works · 1.1% of its workPsychology: 1 fractional works · 1.1% of its workSocial Psychology: 1 fractional works · 1.1% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.5% of its workEconomics and Econometrics: 0 fractional works · 0.5% of its workDecision Sciences: 0 fractional works · 0.3% of its workInformation Systems and Management: 0 fractional works · 0.3% of its workPhysical Sciences: 2 fractional works · 2.6% of its workChemistry: 1 fractional works · 1.7% of its workOrganic Chemistry: 1 fractional works · 1.5% of its workSmaller subfields together: 0 fractional works · 0.1% of its workComputer Science: 0 fractional works · 0.4% of its workComputational Theory and Mathematics: 0 fractional works · 0.4% of its workMaterials Science: 0 fractional works · 0.2% of its workMathematics: 0 fractional works · 0.1% of its workPhysics and Astronomy: 0 fractional works · 0.1% of its workEnvironmental Science: 0 fractional works · 0.1% of its workEngineering: 0 fractional works · 0.1% of its workALL ITS WORKQ Therapeutics(United States)63fractional works, 2022-now
Life Sciences47%Physical Sciences3%Health Sciences33%Social Sciences18%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 18 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology2235.2%
    2. Immunology and Microbiology57.8%
    3. Neuroscience11.5%
    4. Agricultural and Biological Sciences11.4%
    5. Pharmacology, Toxicology and Pharmaceutics00.7%
    1. Medicine2133.3%
    1. Arts and Humanities813.4%
    2. Social Sciences12.3%
    3. Psychology11.1%
    4. Economics, Econometrics and Finance00.5%
    5. Decision Sciences00.3%
    1. Chemistry11.7%
    2. Computer Science00.4%
    3. Materials Science00.2%
    4. Mathematics00.1%
    5. Physics and Astronomy00.1%
    6. Environmental Science00.1%
    7. Engineering00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What does Q Therapeutics (United States) specialise in?

Where its research is concentrated relative to its size: Biochemistry, Genetics and Molecular Biology takes 6.6× the share of its output that it takes of world research.

  1. Biochemistry, Genetics and Molecular BiologyField · 22.1 works6.6×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.29× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 6.61× its world share, 22 worksBiochemistry, Geneti…Immunology and Microbiology: 7.74× its world share, 5 worksImmunology and Micro…Neuroscience: 0.91× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 2.02× its world share, 0 worksPharmacology, Toxico…Chemistry: 1.07× its world share, 1 worksChemistryComputer Science: 0.05× its world share, 0 worksComputer ScienceEnvironmental Science: 0.02× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.05× its world share, 0 worksMaterials ScienceMathematics: 0.08× its world share, 0 worksMathematicsPhysics and Astronomy: 0.04× its world share, 0 worksPhysics and AstronomyMedicine: 1.73× its world share, 21 worksMedicineArts and Humanities: 4.63× its world share, 8 worksArts and HumanitiesDecision Sciences: 0.28× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.25× its world share, 0 worksEconomics, Econometr…Psychology: 0.35× its world share, 1 worksPsychologySocial Sciences: 0.18× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 7.7×. Every wedge is a field page.

All 17 fields, with their numbers
  1. Immunology and Microbiology7.74×5 works
  2. Biochemistry, Genetics and Molecular Biology6.61×22 works
  3. Arts and Humanities4.63×8 works
  4. Pharmacology, Toxicology and Pharmaceutics2.02×0 works
  5. Medicine1.73×21 works
  6. Chemistry1.07×1 works
  7. Neuroscience0.91×1 works
  8. Psychology0.35×1 works
  9. Agricultural and Biological Sciences0.29×1 works
  10. Decision Sciences0.28×0 works
  11. Economics, Econometrics and Finance0.25×0 works
  12. Social Sciences0.18×1 works
  13. Mathematics0.08×0 works
  14. Computer Science0.05×0 works
  15. Materials Science0.05×0 works
  16. Physics and Astronomy0.04×0 works
  17. Environmental Science0.02×0 works

Who are the top researchers at Q Therapeutics (United States)?

Ranked on the quality score, Micah J. Benson, Andrew A. Wylie and Sol Shenker lead among researchers whose main affiliation is Q Therapeutics (United States).

  1. 1 Micah J. Benson United States · #324,594 worldwide 4k citations · 41 works
  2. 2 Andrew A. Wylie United States · #383,871 worldwide 3.2k citations · 192 works
  3. 3 Sol Shenker United States · #416,626 worldwide 2.9k citations · 120 works
  4. 4 Anne E. Dodson United States · #443,981 worldwide 919 citations · 120 works
  5. 5 Erica R. Tobin United States · #665,917 worldwide 1.2k citations · 109 works
  6. 6 Hugh Gannon United States · #733,656 worldwide 1.4k citations · 61 works
  7. 7 Caroline P. Bullock United States · #885,552 worldwide 911 citations · 41 works
  8. 8 Louise Cadzow United States · #1,162,103 worldwide 202 citations · 119 works
  9. 9 Karrie Ka Wai Wong United States · #1,905,044 worldwide 1.2k citations · 108 works
  10. 10 Pamela Sullivan United States · #2,100,330 worldwide 434 citations · 110 works
All ranked researchers at Q Therapeutics (United States)

What are the most cited papers from Q Therapeutics (United States)?

The most cited paper from Q Therapeutics (United States) is "A Python library for probabilistic analysis of single-cell omics data" (Adam Gayoso et al., 2022), with 858 citations. Next come "VISTA is a checkpoint regulator for naïve T cell quiescence and peripheral tolerance" (299) and "Selenoprotein Gene Nomenclature" (285).

Most cited papers
#PaperReleasedCitations
1 A Python library for probabilistic analysis of single-cell omics data Adam Gayoso et al. · Nature Biotechnology Feb 2022 858
2 VISTA is a checkpoint regulator for naïve T cell quiescence and peripheral tolerance Mohamed A. ElTanbouly et al. · Science Open access 16 Jan 2020 299
3 Selenoprotein Gene Nomenclature Vadim N. Gladyshev et al. · Journal of Biological Chemistry Open access 20 Sep 2016 285
4 Modeling alpha-synuclein pathology in a human brain-chip to assess blood-brain barrier disruption Iosif Pediaditakis, Konstantia R. Kodella, Dimitris V. Manatakis et al. · Nature Communications Open access 8 Oct 2021 237
5 Setting Global Standards for Stem Cell Research and Clinical Translation: The 2016 ISSCR Guidelines George Q. Daley et al. · Stem Cell Reports Open access 12 May 2016 228
All 59 most cited papers, with filters and sorting

Which keywords describe research at Q Therapeutics (United States)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Immunotherapy, Cancer Immunotherapy, Cancer, Cultural Heritage, Tumor Regression, Genome Engineering, RNA-Guided and CAR T Cells.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Cancer6▲ 7.0×17 topics
  2. Immunotherapy6▲ 13×11 topics
  3. Cancer Immunotherapy6▲ 60×2 topics
  4. Inflammation5▲ 4.0×19 topics
  5. Cultural Heritage5▲ 16×3 topics
  6. Tumor Regression5▲ 76×2 topics
  7. Genome Engineering4▲ 116×1 topic
  8. RNA-Guided4▲ 116×1 topic
  9. CAR T Cells4▲ 93×1 topic
  10. Chimeric Antigen Receptor4▲ 93×1 topic
  11. Tumor Microenvironment4▲ 15×5 topics
  12. Glycosylation4▲ 61×3 topics
  13. Gene Therapy4▲ 30×4 topics
  14. Cancer Therapy3▲ 9.0×8 topics
  15. Fc Receptors3▲ 90×1 topic
  16. Therapeutic Antibodies3▲ 70×1 topic
  17. Folklore3▲ 83×1 topic
  18. Sufism3▲ 91×2 topics
  19. Turkish Culture3▲ 135×1 topic
  20. Innate Immunity3▲ 13×4 topics
  21. Homologous Recombination2▲ 81×2 topics
  22. Immune Checkpoint Blockade2▲ 34×1 topic
  23. PD-1 and PD-L12▲ 34×1 topic
  24. Immunity2▲ 8.9×3 topics
  25. Linguistics2▲ 24×1 topic
  26. Turkic2▲ 142×1 topic
  27. Genomic Integration2▲ 63×2 topics
  28. AAV2▲ 84×1 topic
  29. Cell Death2▲ 14×4 topics
  30. Metabolism2▲ 6.5×5 topics
  31. Transcriptional Regulation2▲ 21×5 topics
  32. Viral Vectors2▲ 84×1 topic
  33. Divan Poetry2▲ 126×1 topic
  34. Turkish Literature2▲ 126×1 topic
  35. Angiogenesis2▲ 8.7×6 topics
  36. Antigen Presentation2▲ 32×2 topics
  37. Genomic Instability2▲ 22×2 topics
  38. Targeted Therapy2▲ 11×5 topics
  39. Dendritic Cells2▲ 26×1 topic
  40. Tumor Antigen2▲ 38×1 topic

Which research topics does Q Therapeutics (United States) publish most on?

By volume in 2022-now: CRISPR and Genetic Engineering, CAR-T cell therapy research, Monoclonal and Polyclonal Antibodies Research and Cultural and Sociopolitical Studies.

CRISPR and Genetic Engineering: 4 fractional worksCAR-T cell therapy research: 4 fractional worksMonoclonal and Polyclona…3Monoclonal and Polyclonal Antibodies Research: 3 fractional worksCultural and Sociopoliti…3Cultural and Sociopolitical Studies: 3 fractional worksCancer Immunotherapy and Biomarkers: 2 fractional worksLinguistics and Cultural Studies: 2 fractional worksVirus-based gene therapy…2Virus-based gene therapy research: 2 fractional worksTurkish Literature and Culture: 2 fractional worksImmunotherapy and Immune Responses: 2 fractional worksDNA Repair Mechanisms1DNA Repair Mechanisms: 1 fractional works
Molecular BiologyOncologyRadiology, Nuclear Medicine and ImagingMuseology4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 CRISPR and Genetic Engineering Molecular Biology 4 works
  2. 2 CAR-T cell therapy research Oncology 4 works
  3. 3 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 3 works
  4. 4 Cultural and Sociopolitical Studies Museology 3 works
  5. 5 Cancer Immunotherapy and Biomarkers Oncology 2 works
  6. 6 Linguistics and Cultural Studies Language and Linguistics 2 works
  7. 7 Virus-based gene therapy research Genetics 2 works
  8. 8 Turkish Literature and Culture Literature and Literary Theory 2 works
  9. 9 Immunotherapy and Immune Responses Immunology 2 works
  10. 10 DNA Repair Mechanisms Molecular Biology 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available50.1%not open49.9%

World: 40% of research is openly available.

with international co-authors20.3%domestic only79.7%

World: 18% is written across borders.

How has Q Therapeutics (United States)'s research output changed?

Output in 2022-2025 was 136% higher than in 2018-2021.

still counting200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Q Therapeutics (United States) as a percentage of every work published that year, 0.00018% in 2024.

still counting0.00010%0.00020%0.00030%Q Therapeutics (United States)0.00029% in 2025200020102020

Fractional works of Q Therapeutics (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Salt Lake City

All research institutions in Salt Lake City

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Q Therapeutics (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.